• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.

作者信息

Fioretti P, Gambacciani M, Spinetti A, Cagnacci A, Paoletti A M, Felipetto R, Melis G B

机构信息

Department of Obstetrics and Gynecology, University of Pisa, School of Medicine, Italy.

出版信息

Ann N Y Acad Sci. 1991;622:302-6. doi: 10.1111/j.1749-6632.1991.tb37875.x.

DOI:10.1111/j.1749-6632.1991.tb37875.x
PMID:1829595
Abstract
摘要

相似文献

1
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.在一项为期两年的前瞻性研究中，使用经皮17β-雌二醇和口服醋酸甲羟孕酮预防绝经后骨质流失及子宫内膜反应。
Ann N Y Acad Sci. 1991;622:302-6. doi: 10.1111/j.1749-6632.1991.tb37875.x.
2
A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.一项关于释放雌二醇的阴道环联合口服孕激素与经皮雌激素联合释放左炔诺孕酮宫内节育器效果的对比研究：临床发现及子宫内膜反应
Int J Fertil Menopausal Stud. 1996 Nov-Dec;41(6):522-7.
3
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Obstet Gynecol. 1988 Sep;72(3 Pt 1):323-7.
4
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.经皮与口服序贯孕激素联合经皮雌二醇的比较：对出血模式和子宫内膜组织学的影响。
Obstet Gynecol. 1993 Nov;82(5):773-9.
5
[Dihydrogesterone vs. medroxyprogesterone acetate in association with transdermal estradiol in postmenopausal substitution treatment].[双氢孕酮与醋酸甲羟孕酮联合经皮雌二醇用于绝经后替代治疗的比较]
Minerva Ginecol. 1994 Apr;46(4):179-82.
6
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.孕激素拮抗经皮雌激素给药对不同年龄绝经后女性生长激素和胰岛素样生长因子-I的影响。
J Clin Endocrinol Metab. 1991 Jan;72(1):172-8. doi: 10.1210/jcem-72-1-172.
7
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
J Gerontol. 1991 Nov;46(6):M216-22. doi: 10.1093/geronj/46.6.m216.
8
[Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Gynakol Rundsch. 1990;30(3):133-43.
9
Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.炔诺酮和醋酸甲羟孕酮与天然孕酮及雌二醇在刺激培养的子宫内膜基质细胞产生催乳素方面的比较。
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1932-8. doi: 10.1016/0002-9378(90)90776-4.
10
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.经皮雌激素联合左炔诺孕酮宫内节育器治疗更年期症状：临床及子宫内膜反应
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9. doi: 10.1016/0002-9378(95)90095-0.

引用本文的文献

1
Optimisation of treatment by applying programmable rate-controlled drug delivery technology.应用可编程速率控制药物递送技术优化治疗。
Clin Pharmacokinet. 2002;41(15):1267-99. doi: 10.2165/00003088-200241150-00003.
2
Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.激素替代疗法：II. 对其在预防绝经后骨质疏松症和缺血性心脏病中作用的药物经济学评估。
Pharmacoeconomics. 1994 Jun;5(6):513-54. doi: 10.2165/00019053-199405060-00007.
3
A risk-benefit appraisal of transdermal estradiol therapy.
经皮雌二醇治疗的风险效益评估。
Drug Saf. 1993 Nov;9(5):365-79. doi: 10.2165/00002018-199309050-00005.
4
Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.经皮雌二醇。其药理学特性及预防绝经后骨质疏松症治疗潜力的综述。
Drugs Aging. 1992 Nov-Dec;2(6):487-507. doi: 10.2165/00002512-199202060-00005.